  squibb sqb interest bui cetu  author    marjori shaffer, reutersauthor     new york, june  - robert fildes, presid chief execut cetu corp ctus.o, told reuter squibb corp interest bui cetus. 
    earlier compani squibb bui cetu five equiti postion cetu  mln dlrs. 
    attempt squibb becom major major holder cetus, fild told reuter interview. 
squibb approach indic want acquir wouldnt interest kind arrangement, fildes. 
    squibb reach comment late comment fildes. 
    squibb cetu first pharmaceut partner on equiti posit cetus. 
eastman kodak co ek w.r. 
grace wr both joint ventur cetus, own equiti posit company, fildes. 
    cetu ventur kodak develp diagnost product grace develop agricultur products. 
    earlier, squibb cetu announc joint statement  agreement principl form joint ventur develop new biotechnolog product sever fields. 
        part deal squibb licens sever cetu anticanc agents, includ interleukin-, development. 
squibb sell drug japan market north american western europe. 
    wouldnt done deal understood cetu build fulli integr busi north america europe, fildes. 
    squibb good partner squibb major joint ventur japan sale capabl market. 
        fild cetu shun licens arrang pharmaceut compani want build business. 
mani larg corpor invest small biotech firms. 
    squibb invest cetu first made biotechnology. 
fild attract cetu want partner didnt relationship larg number biotechnolog companies. 
        fild strategi partner non drug area diagnost agriculture, keep biggest develop anticanc drug ourselves. 
    fild partnership squibb us broaden compani reach such big monei make area cardiovascular, anti-infect anti-inflammatori markets. 
    squibb investm  mln dlr cetu research over next five years. 
        squibb put up over  mln dlr research develop make happen, equiti posit part packag simpli demonstr serious partnership, fildes.
